TGFB1 and Myocardial fibrosis: Preclinical experiment indicates that activation of the Nrf2/HO-1 signaling axis inhibits the TGF-β1/Smad2/3 signaling pathway, effectively suppressing myocardial fibrosis in the DCM mice model (46, 47).